Inogen (INGN) Current Deferred Revenue (2013 - 2026)

Inogen (INGN) has 14 years of Current Deferred Revenue data on file, last reported at $5.1 million in Q1 2026.

• On a quarterly basis, Current Deferred Revenue fell 20.59% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a 20.59% decrease from a year earlier, with the FY2025 full-year figure at $5.5 million, down 17.3% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $5.1 million, down from $5.5 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for INGN reached as high as $9.1 million in Q3 2022 and fell as low as $5.1 million in Q1 2026.
• Historically, Current Deferred Revenue has averaged $7.5 million across 5 years, with a median of $7.4 million in 2024.
• Across the five-year window, Current Deferred Revenue gained 15.98% in 2022 and dropped 20.59% in 2026, its largest moves.
• Year by year, Current Deferred Revenue stood at $8.9 million in 2022, then dropped by 10.14% to $8.0 million in 2023, then fell by 16.62% to $6.7 million in 2024, then declined by 17.3% to $5.5 million in 2025, then slipped by 7.5% to $5.1 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $5.1 million in Q1 2026, $5.5 million in Q4 2025, and $6.0 million in Q3 2025.